Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 10/20 | 0.68 |
| ▸ | P2RY11 | Q96G91 | 4/20 | 0.68 |
| ▸ | ENPP1 | P22413 | 3/20 | 0.68 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.68 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.68 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.68 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.68 |
| ▸ | P2RY12 | Q9H244 | 2/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19503942 | 0.99 | P2RY1 (0.67) | P2RY1P2RY11ENPP1P2RX1P2RX3 | |
| SCHEMBL19503345 | 0.88 | P2RY1 (0.57) | P2RY1P2RY11ENPP1P2RX1P2RX3 | |
| SCHEMBL19503471 | 0.87 | P2RY1 (0.68) | P2RY1P2RY11ENPP1P2RX1P2RX3 | |
| SCHEMBL21257341 | 0.83 | P2RX1 (0.60) | P2RY1P2RY11P2RX1P2RX3P2RX4 | |
| SCHEMBL21257342 | 0.82 | P2RY1 (0.69) | P2RY1P2RY11ENPP1P2RX1P2RX3 | |
| SCHEMBL375601 | 0.81 | P2RY1 (1.00) | P2RY1P2RY11ENPP1P2RX1P2RX3 | |
| SCHEMBL29381860 | 0.81 | P2RY1 (1.00) | P2RY1P2RY11ENPP1P2RX1P2RX3 | |
| SCHEMBL375602 | 0.81 | P2RY1 (1.00) | P2RY1P2RY11ENPP1P2RX1P2RX3 | |
| SCHEMBL10120953 | 0.81 | P2RY1 (1.00) | P2RY1P2RY11ENPP1P2RX1P2RX3 | |
| SCHEMBL21257386 | 0.80 | P2RY1 (0.70) | P2RY1P2RY11ENPP1P2RX1P2RX3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019157317-A1 | COMPOUNDS AND METHODS FOR TREATING ADDICTION AND RELATED DISORDERS | ASTROCYTE PHARMACEUTICALS, INC. (US) | 2019-08-15 | — | — | WO | disclosed |
| WO-2017185061-A1 | COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS | ASTROCYTE PHARMACEUTICALS, INC. (US) | 2017-10-26 | — | — | WO | disclosed |